Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
We must not pit immigration policy and health care needs against one another. We need better policy on immigration, and that policy should confront immigration at the workplace and at the border—not in the hospital emergency room.
White Coats for Black Lives advocates that American medicine address racial inequities in health and health care by promoting diversity, eliminating implicit racial bias in the physician workforce, and advocating for equitable social structures.
AMA J Ethics. 2015;17(10):978-982. doi:
10.1001/journalofethics.2015.17.10.sect1-1510.
Physician-assisted doping of athletes has transformed high-performance sport into a chronically overmedicated subculture and spread so-called hormonal rejuvenation to the general public.
Marwan Hariz, MD, PhD and Jordan P. Amadio, MD, MBA
Deep brain stimulation (DBS) for enhancements of non-disease states is ethically indefensible given our incomplete knowledge of this technology. Attention should instead be focused on increasing access to DBS for patients with illnesses potentially treatable by the procedure.
Concerns about the deleterious effects of stress on the mind and body have led to the beginnings of a stress vaccine, an injection that will reduce these effects.